Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 08, 2021 08:30 ET | Source: Acasti Pharma, Inc.

Acasti Pharma to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

LAVAL, Québec, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST) today announced that Jan D’Alvise, President and Chief Executive...
August 27, 2021 08:40 ET | Source: Acasti Pharma, Inc.

Acasti Pharma Announces Successful Completion of its Merger with Grace Therapeutics, Inc., Voting Results of its Annual and Special Meeting of Shareholders and Reverse Stock Split

LAVAL, Québec, Aug. 27, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti”) (NASDAQ: ACST–TSX-V: ACST), announced today the completion of its previously disclosed acquisition of Grace...
August 12, 2021 07:00 ET | Source: Acasti Pharma, Inc.

Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2022

August 4th webcast replay discussing planned acquisition of Grace Therapeutics available on the Company’s website Shareholders urged to vote in advance of upcoming shareholder meeting on August...
July 29, 2021 08:30 ET | Source: Acasti Pharma, Inc.

Reminder: Acasti Pharma to Host Conference Call on August 4th at 1:00 PM ET to Discuss Planned Acquisition of Grace Therapeutics

LAVAL, Québec, July 29, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST) announces a reminder that it will host a business update...
July 23, 2021 08:30 ET | Source: Acasti Pharma, Inc.

Acasti Pharma Schedules Conference Call for August 4th at 1:00 PM ET to Discuss Planned Acquisition of Grace Therapeutics

LAVAL, Québec, July 23, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST) announces it will host a business update conference call on...
June 22, 2021 07:00 ET | Source: Acasti Pharma, Inc.

Acasti Pharma Provides Fiscal 2021 Year-End Business Update

LAVAL, Québec, June 22, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST) today announced its operating and financial results for the fiscal...
May 17, 2021 07:00 ET | Source: Acasti Pharma, Inc.

Acasti Intends to Request Hearing Before Nasdaq Panel to Present Plan of Compliance

LAVAL, Québec, May 17, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST) today announced that, on May 11, 2021, the Company received notice...
May 07, 2021 07:00 ET | Source: Acasti Pharma, Inc.

Acasti Announces Definitive Agreement to Acquire Grace Therapeutics, Inc.

Grace provides Acasti with a pipeline of rare and orphan disease programs, including 3 clinical stage assets that have received Orphan Drug Designation from the FDA Expects lead asset to complete PK...
March 08, 2021 17:30 ET | Source: Acasti Pharma, Inc.

Acasti Pharma Provides Update on Recent Financing Activities

LAVAL, Quebec, March 08, 2021 (GLOBE NEWSWIRE) -- As required pursuant to the policies of the TSX Venture Exchange, Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST) is...
February 09, 2021 06:55 ET | Source: Acasti Pharma, Inc.

Acasti Pharma Announces Results for Third Quarter of Fiscal 2021

LAVAL, Quebec, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST) today announced its operating and financial results for the third quarter...